Utility of the 2019 EULAR/ACR SLE classification criteria for predicting mortality and hospitalisation: development and cross-validation of ominosity score

被引:0
作者
Figueroa-Parra, Gabriel [1 ,2 ]
Hanson, Andrew C. [3 ]
Sanchez-Rodriguez, Alain [1 ]
Meade-Aguilar, Jose A. [1 ,4 ]
Gonzalez-Trevino, Mariana [1 ,5 ]
Cuellar-Gutierrez, Maria C. [1 ,6 ]
Barbour, Kamil E. [7 ]
Duarte-Garcia, Ali [1 ,8 ]
Crowson, Cynthia [1 ,3 ]
机构
[1] Mayo Clin, Div Rheumatol, Rochester, MN 55905 USA
[2] Hosp Univ Dr Jose Eleuterio Gonzalez, Div Haematol, Monterrey, Nuevo Leon, Mexico
[3] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA
[4] Boston Univ, Chobanian & Avedisian Sch Med, Dept Med, Boston, MA USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[6] Hosp Salvador, Santiago, Chile
[7] Ctr Dis Control & Prevent, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
[8] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deliv, Rochester, MN 55905 USA
来源
RMD OPEN | 2024年 / 10卷 / 04期
关键词
Mortality; Lupus Erythematosus; Systemic; Epidemiology; Outcome Assessment; Health Care; Classification; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SURVIVAL; METAANALYSIS; PROFILE; CARE;
D O I
10.1136/rmdopen-2024-004833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria score (>= 20 points) has been associated with poor outcomes. We aimed to evaluate its utility as a predictor for mortality and hospitalisation and to derive and validate an ominosity score based on the SLE classification criteria set.Methods Incident patients with SLE in a population-based cohort were included. The association between the 2019 EULAR/ACR SLE score and mortality and hospitalisation was assessed using Cox regression adjusted for age, sex and calendar year. An ominosity score for mortality was developed based on the SLE criteria set. The least absolute shrinkage and selection operator method was used to estimate model coefficients. Concordance and calibration were assessed by cross-validation and by plotting the observed event rates against the deciles of predicted probabilities.Results Among 374 patients with incident SLE, a EULAR/ACR score >= 20 points was not associated with an increased risk of mortality (HR 1.17, 95% CI 0.67 to 2.03) or first hospitalisation (HR 1.14, 95% CI 0.79 to 1.64) compared with a score <= 19 points. The derived ominosity score for mortality included age, sex, thrombocytopaenia, neuropsychiatric manifestations, subacute cutaneous or discoid lupus, non-scarring alopecia, inflammatory arthritis, renal involvement, antiphospholipid antibodies and hypocomplementaemia. This model demonstrated a concordance=0.76 with adequate calibration. Age and sex were the main predictors, as seen in the model including just age, sex and year (concordance=0.77).Conclusion The 2019 EULAR/ACR SLE criteria score was not associated with mortality and hospitalisation. The derived ominosity score for mortality presented good prediction for mortality but was not better than age and sex alone.
引用
收藏
页数:8
相关论文
共 26 条
  • [1] Toward new criteria for systemic lupus erythematosusa standpoint
    Aringer, M.
    Doerner, T.
    Leuchten, N.
    Johnson, S. R.
    [J]. LUPUS, 2016, 25 (08) : 805 - 811
  • [2] Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1002/art.40930, 10.1136/annrheumdis-2018-214819]
  • [3] Hospitalizations among Danish SLE patients: a prospective study on incidence, causes of admission and risk factors in a population-based cohort
    Busch, R. W.
    Kay, S. D.
    Voss, A.
    [J]. LUPUS, 2018, 27 (01) : 165 - 171
  • [4] Comparison of Three Classification Criteria Sets for Systemic Lupus Erythematosus: A Study Looking at Links to Outcome and Mortality
    Carneiro, Antonio Costa
    Ruiz, Marta Mozo
    Freitas, Sara
    Isenberg, David
    [J]. ARTHRITIS CARE & RESEARCH, 2020, 72 (11) : 1611 - 1614
  • [5] Health Care Utilization in Systemic Lupus Erythematosus in the Community The Lupus Midwest Network
    Chevet, Baptiste
    Figueroa-Parra, Gabriel
    Valenzuela-Almada, Maria O.
    Hocaoglu, Mehmet
    Vallejo, Sebastian
    Osei-Onomah, Shirley-Ann
    Giblon, Rachel E.
    Dabit, Jesse Y.
    Chamberlain, Alanna M.
    Cornec, Divi
    Greenlund, Kurt J.
    Barbour, Kamil E.
    Crowson, Cynthia S.
    Duarte-Garcia, Ali
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (01) : 29 - 35
  • [6] Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan
    Chiu, Y-M
    Lai, C-H
    [J]. LUPUS, 2010, 19 (10) : 1250 - 1255
  • [7] Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.1016/j.eururo.2014.11.025, 10.1002/bjs.9736, 10.7326/M14-0698]
  • [8] General cardiovascular risk profile for use in primary care - The Framingham Heart Study
    D'Agostino, Ralph B.
    Vasan, Ramachandran S.
    Pencina, Michael J.
    Wolf, Philip A.
    Cobain, Mark
    Massaro, Joseph M.
    Kannel, William B.
    [J]. CIRCULATION, 2008, 117 (06) : 743 - 753
  • [9] All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database
    Dhital, Rashmi
    Pandey, Ramesh Kumar
    Poudel, Dilli Ram
    Oladunjoye, Olubunmi
    Paudel, Prakash
    Karmacharya, Paras
    [J]. RHEUMATOLOGY INTERNATIONAL, 2020, 40 (03) : 393 - 397
  • [10] Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades
    Duarte-Garcia, Ali
    Hocaoglu, Mehmet
    Valenzuela-Almada, Maria
    Osei-Onomah, Shirley-Ann
    Dabit, Jesse Y.
    Sanchez-Rodriguez, Alain
    Duong, Stephanie Q.
    Giblon, Rachel E.
    Langenfeld, Hannah E.
    Alarcon, Graciela S.
    Helmick, Charles G.
    Crowson, Cynthia S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (09) : 1260 - 1266